LIG's condom price control lifted: Government forces Durex maker to abandon exclusive supply agreements
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Price controls are to be lifted from condoms produced by London International Group, the healthcare group that owns the Durex brand.
But the Government intends to limit LIG's ability to push up its prices by forcing it to abandon the use of exclusive supply agreements with retailers and wholesalers.
The decision by Neil Hamilton, the corporate affairs minister, follows the recommendations of a recent inquiry by the Monopolies and Mergers Commission.
The move is in effect a response to the runaway success of Mates, the condom brand launched by Richard Branson's Virgin group but now owned by Ansell Corporation, the Australian company that is part of Pacific Dunlop.
Price controls on LIG were introduced in 1982, following an earlier MMC inquiry. That concluded that LIG - which at that time controlled 91 per cent of the market - had a monopoly position which operated against the public interest.
LIG was accordingly made to adhere to a complex price formula that restricted increases to at least 1.5 per cent below an index of production costs. However, Mates has now captured more than 20 per cent of the market and LIG's share has fallen to 75 per cent.
As well as giving up exclusive supply agreements LIG's prices - and especially its sales to the National Health Service, which accounts for almost a fifth of all condoms used in the UK - are to be monitored by Sir Bryan Carsberg, director general of fair trading.
LIG said it was extremely pleased with the relaxation, which would increase customer choice and boost product development. However, the move is unlikely to have a significant impact on profits. Its UK condom business makes up less than 5 per cent of sales.
Mr Hamilton said the changes would lead to increased competition and more advertising and promotional campaigns. This would help to stimulate condom usage, 'with important benefits for public health and welfare'.
(Photograph omitted)
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments